Evidence map›Paper›PMID 38202548›Full record

ArticleNanomaterials (Basel, Switzerland)2023

In Vivo Evaluation of Bone Regenerative Capacity of the Novel Nanobiomaterial: β-Tricalcium Phosphate Polylactic Acid-co-Glycolide (β-TCP/PLLA/PGA) for Use in Maxillofacial Bone Defects.

Mrunalini Ramanathan, Ankhtsetseg Shijirbold, Tatsuo Okui, Hiroto Tatsumi, Tatsuhito Kotani, Yukiho Shimamura, Reon Morioka, Kentaro Ayasaka, Takahiro Kanno

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mrunalini RamanathanDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Ankhtsetseg ShijirboldDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Tatsuo OkuiDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Hiroto TatsumiDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Tatsuhito KotaniDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Yukiho ShimamuraDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Reon MoriokaDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Kentaro AyasakaDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Takahiro KannoDepartment of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, 89-1, Enya-Cho, Izumo 693-8501, Shimane, Japan.
Shimane University · JP

Funding

JSPS KAKENHI 21K10042
6 · The paper itself

Abstract

Maxillofacial bone defects are treated by autografting or filling with synthetic materials in various forms and shapes. Electrospun nanobiomaterials are becoming popular due to their easy placement and handling; combining ideal biomaterials extrapolates better outcomes. We used a novel electrospun cotton-like fiber made from two time-tested bioresorbable materials, β-TCP and PLLA/PGA, to check the feasibility of its application to maxillofacial bone defects through an in vivo rat mandibular bone defect model. Novel β-TCP/PLLA/PGA and pure β-TCP blocks were evaluated for new bone regeneration through assessment of bone volume, inner defect diameter reduction, and bone mineral density. Bioactive/osteoconductivity was checked by scoring the levels of Runt-related transcription factor x, Leptin Receptor, Osteocalcin, and Periostin biomarkers. Bone regeneration in both β-TCP/PLLA/PGA and β-TCP was comparable at initial timepoints. Osteogenic cell accumulation was greater in β-TCP/PLLA/PGA than in β-TCP at initial as well as late phases. Periostin expression was more marked in β-TCP/PLLA/PGA. This study demonstrated comparable results between β-TCP/PLLA/PGA and β-TCP in terms of bone regeneration and bioactivity, even with a small material volume of β-TCP/PLLA/PGA and a decreased percentage of β-TCP. Electrospun β-TCP/PLLA/PGA is an ideal nanobiomaterial for inducing bone regeneration through osteoconductivity and bioresorbability in bony defects of the maxillofacial region.

Indexed as

electrospun nanobiomaterialmaxillofacial bone regenerationsynthetic/artificial bone graft substitutesβ-TCP/PLLA/PGA cotton-like fiberβ-tricalcium phosphate

Identifiers

PMID38202548
PMCPMC10780666
OpenAlexW4390338914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.